Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV
· Real-Time Price · USD
11.84
0.09 (0.77%)
At close: Aug 15, 2025, 3:59 PM
11.85
0.08%
After-hours: Aug 15, 2025, 05:36 PM EDT
Roivant Sciences Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Revenue | 76.19M | 97.56M | 125.68M | 158.3M | 124.8M | 123.24M | 103.15M | 66.05M | 44.43M | 17.05M |
Cost of Revenue | 6.49M | 10.7M | 14.11M | 15.32M | 15.56M | 20.53M | 25.19M | 21.92M | 17.71M | 8.32M |
Gross Profit | 70.14M | 88.67M | 113.39M | 142.98M | 109.23M | 102.71M | 77.96M | 44.13M | 26.72M | 8.73M |
Operating Income | -1.02B | -1B | 4.33B | 4.95B | 4.79B | 4.83B | -514.45M | -790.91M | -514.49M | -280.33M |
Interest Income | 258.38M | 287.21M | 257.31M | 201.84M | 146.43M | 77.25M | 55.55M | 41.25M | 24.53M | 10.25M |
Pretax Income | -591.8M | -580.2M | 4.75B | 4.65B | 4.25B | 4.27B | -1.21B | -887.39M | -561.29M | -382.08M |
Net Income | -171.98M | -116.62M | 4.81B | 4.74B | 4.35B | 4.47B | -981.77M | -677.45M | -385.63M | -352.01M |
Selling & General & Admin | 591.41M | 661.47M | 717.2M | 679.77M | 687.44M | 638.13M | 604.37M | 440.01M | 283.82M | 163.52M |
Research & Development | 550.41M | 538.05M | 520.18M | 509.81M | 501.74M | 512.69M | 514.51M | 382.52M | 257.39M | 125.53M |
Other Expenses | -10.76M | -110.39M | -5.46B | -6B | -5.87B | -5.87B | -526.46M | 12.5M | n/a | n/a |
Operating Expenses | 1.09B | 1.09B | -4.22B | -4.81B | -4.69B | -4.72B | 592.42M | 835.03M | 541.21M | 289.06M |
Interest Expense | 13.4M | 20.57M | 30.02M | 39.27M | 34.78M | 36.18M | 35.18M | 25.93M | 17.02M | 8.45M |
Selling & Marketing Expenses | n/a | -1.09M | -1.09M | n/a | 156.19M | 156.19M | 156.19M | 156.19M | n/a | n/a |
Cost & Expenses | 1.1B | 1.1B | -4.21B | -4.79B | -4.67B | -4.7B | 617.61M | 856.96M | 558.92M | 297.38M |
Income Tax Expense | 48.87M | -9.41M | 41.83M | 33.13M | 22.22M | 27.39M | 4.54M | 778K | -974K | 2.82M |
Shares Outstanding (Basic) | 707.3M | 722.72M | 735.47M | 735.82M | 802.86M | 800.59M | 770.23M | 759.27M | 742.54M | 713.32M |
Shares Outstanding (Diluted) | 707.3M | 722.72M | 735.47M | 781.63M | 802.86M | 844.46M | 770.23M | 759.27M | 742.54M | 713.32M |
EPS (Basic) | -0.24 | -0.14 | 6.00 | 5.91 | 5.40 | 5.54 | -1.32 | -0.92 | -0.54 | -0.49 |
EPS (Diluted) | -0.25 | -0.15 | 5.65 | 5.56 | 5.06 | 5.20 | -1.32 | -0.92 | -0.54 | -0.49 |
EBITDA | -689.14M | 4.71B | 4.67B | 4.58B | 4.18B | -1.1B | -1.09B | -778.27M | -468.55M | -305.42M |
EBIT | -618.27M | 4.69B | 10.07B | 9.98B | 9.58B | 4.3B | -1.18B | -861.45M | -544.27M | -373.63M |
Depreciation & Amortization | 13.05M | 16.89M | 20.34M | 21.08M | 22.04M | 24.32M | 25.9M | 20.31M | 14.47M | 6.97M |